2Eckstein A, Quadbeck B, Mueller G, et al Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol. 2003;87:773-776
3Marcocci C, Marino M, Rocchi R, et al Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy. J Endocrinol Invest 2004; 27(3):272-280
4Tanikawa T, Okada Y, Tanaka Y, et al Intravenous cyclophosphamide pulse therapy is effective for refractory Graves' ophthalmopathy. J UOEH 2006;28(2): 185-191
5Brain R Cortisone in exophthalmos: Report on a therapeutic trial of cortisone and corticotrophin(ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1995;I:6-9
6Wiersinga WM Advances in medical therapy of thyroid-associated ophthalmopathy. Orbit 1996; 15:177-186
7Prummel MF, Mourits Mph, Berghout A, et al Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 1989;321:1353-1359
8Prummel MF, Wiersinga WM, Mourits Mph, et al Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 1990; 150:1098-1011
9Prummel MF, Wiersinga WM Smoking and risk of Graves' disease. JAMA 1993;269:479-482
10Prummel MF, Mourits Mph, Blank L, et al Randomized doubleblind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993;342:949-954
